Roivant Sciences Ltd. Common Shares
Symbol: ROIV (NASDAQ)
15.50
▲ (2.45%) 0.370
Company Description:
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Key Stats
- Today's Open: $15.13
- Today's High: $16.118
- Today's Low: $14.81
- Today's Volume: 10.71M
- Yesterday Close: $15.13
- Yesterday High: $15.27
- Yesterday Low: $14.925
- Yesterday Volume: 6.26M
- Last Min Volume: 1
- Last Min High: $15.5
- Last Min Low: $15.5
- Last Min VWAP: $15.5
Company Profile
- Name: Roivant Sciences Ltd. Common Shares
- Website: https://www.roivant.com
- Listed Date: 2021-10-01
- Location: LONDON,
- Market Status: Active
- CIK Number: 0001635088
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $10.33B
- Round Lot: 100
- Outstanding Shares: 682.88M
- Asset Type: CS
RECENT FILINGS FOR ROIV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-09-23 | 4 | View |
| 2025-09-23 | 144 | View |
| 2025-09-22 | 144 | View |
| 2025-09-22 | 144 | View |
| 2025-09-19 | 144 | View |
| 2025-09-18 | 4 | View |
| 2025-09-17 | 8-K | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-11 | 8-K | View |
| 2025-09-05 | 4 | View |
| 2025-09-03 | 8-K | View |
| 2025-09-02 | 4 | View |
| 2025-08-22 | 4 | View |
Latest News on ROIV